
Malex500 mg+25
Ibn-Sina Pharmaceuticals Ltd.
Sulphadoxine + Pyrimethamine is a fixed-dose combination antimalarial (a sulfonamide plus an antifolate) used for: Established use: Treatment of acute and more.
Sulphadoxine + Pyrimethamine is a fixed-dose combination antimalarial (a sulfonamide plus an antifolate) used for:
Sulphadoxine + Pyrimethamine is not effective against chloroquine-sensitive strains alone and is not used for severe or complicated malaria, for which parenteral antimalarials are required.
| Indication | Population | Dose |
|---|---|---|
| Acute uncomplicated P. falciparum malaria (treatment) | Adults | 2–3 tablets (sulfadoxine 500 mg/pyrimethamine 25 mg each) as a single oral dose |
| Children (over 2 months of age) | Weight/age-based single dose, ranging from about ¼–½ tablet in infants to 3 tablets in older children/adolescents; a physician should calculate the exact weight-based dose | |
| Malaria chemoprophylaxis (travelers, when alternatives are unsuitable) | Adults | 1 tablet once weekly, or 2 tablets every 2 weeks, starting 1–2 days before travel and continued for 4–6 weeks after leaving the endemic area |
| Children | Weight-based fraction of the adult dose, on the same weekly/biweekly schedule | |
| IPTp (intermittent preventive treatment in pregnancy), endemic areas | Pregnant women, per WHO/antenatal care schedule | A single treatment-dose course given under direct observation at each scheduled antenatal visit starting in the second trimester, spaced at least one month apart, per national malaria control program guidance |
Tablets should be swallowed whole with plenty of fluid, generally after a meal to reduce gastrointestinal upset. Complete the full prescribed dose exactly as directed by the physician; do not repeat or extend dosing beyond what is prescribed, and do not share Sulphadoxine + Pyrimethamine with others, as inappropriate use promotes resistance and increases the risk of serious adverse reactions.
Most patients receiving single-dose Sulphadoxine + Pyrimethamine for malaria treatment tolerate it well. Reported adverse effects include:
Sulphadoxine + Pyrimethamine should be discontinued immediately and medical attention sought at the first sign of skin rash, mucosal lesions, unexplained bruising/bleeding, sore throat, fever, pallor, or jaundice, as these may herald a serious hypersensitivity or hematologic reaction.
Sulphadoxine + Pyrimethamine is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.